Organogenesis Inc. (ORGO) - Aggregate Business Assets

Official company branding of Organogenesis Corp (ORGO)

This daily price chart for Organogenesis Holdings (ORGO) illustrates total assets currently valued at 545.62. The Organogenesis Holdings team brings together dedicated bioengineers striving to prevent amputations through regeneration. Market capitalization is driven by the sale of innovative materials for ulcer healing and tissue restoration. Strict FDA regulations and an extensive patent portfolio ensure a high barrier to entry in the industry.

ORGO (Organogenesis Inc.) Company Total Assets history from 07/04/2022 to 10/31/2026

Comprehensive metric breakdowns and analytics for Organogenesis Inc. (ORGO)

- stock value and consensus price forecast:
Market Price organogenesis.com|ORGO - Consensus Target
- market capitalization indicators:
Market Value Organogenesis Corp|ORGO - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Organogenesis|ORGO - Book Capitalization|Market-to-Book Ratio organogenesis.com|ORGO - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Organogenesis Holdings|ORGO - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Organogenesis Corp|ORGO - Company Debts|Debt to Book Value Organogenesis Corp|ORGO - Company Long-Term Debts|Short-Term Debt Organogenesis|Immediate Liquidity Ratio organogenesis.com
- net income and valuation multiples indicators:
ORGO - Net Income
Basic company analysis:ORGO, organogenesis.com
Manufactured product of Organogenesis Holdings Inc.

High barriers to entry in the biologics sector, driven by patents on cellular technologies, define the resource structure of Organogenesis Holdings (ORGO). An analysis of total asset history, calculated reverse-engineered via ROA, allows for a real-time assessment of the company's tangible and intangible assets over time, revealing capital efficiency relative to current market capitalization and the risks of excessive capital lock-up.

Direct competitors

Company Assets HCA Healthcare (HCA)|Cumulative Company Assets THC|FMS (Fresenius Medical Care AG) - Aggregate Business Assets|Aggregate Company Assets Solventum Inc. (SOLV)|EHC (Encompass) - Aggregate Asset Value|Company Total Assets UHS (Universal Health Services, Inc.)|davita.com (DVA) - Company Assets|RadNet - Company Total Assets|OPCH - Company Total Assets|SGRY (Surgery Partners Corp) - Cumulative Company Assets|PINC: Aggregate Business Assets|Aggregate Company Assets National Vision Holdings|Cumulative Company Assets progyny.com (PGNY)|Company Total Assets ARDT|SEM - Company Assets|Aggregate Company Assets Apollo Medical Holdings ASTH|MD: Total Business Assets|USPH: Cumulative Company Assets|pennantgroup.com - Aggregate Business Assets|Nutex Health (NUTX) - Aggregate Company Assets|Company Assets Auna S.A. (AUNA)|Aggregate Company Assets SBC Medical Group Holdings Inc|EOLS: Aggregate Asset Value|Company Total Assets CYH|beautyhealth.com (SKIN) - Company Balance Sheet Assets|Company Total Assets MDWD (MediWound)|Company Total Assets Biote BTMD|JYNT - Aggregate Company Assets|DCGO (DocGo, Inc) - Total Business Assets|p3hp.org (PIII) - Aggregate Company Assets|Company Assets gaintherapeutics.com (GANX)|EUDA (EUDA Health Holdings Limited) - Company Total Assets|BMGL - Company Balance Sheet Assets|Company Total Assets CLGN|CUPR - Company Assets|Aggregate Company Assets Concord Medical Services CCM|AMS: Total Business Assets|MEDIROM Healthcare Group - Company Total Assets|Company Assets Avalon GloboCare|DIH Holding US Inc. (DHAI) - Aggregate Company Assets|XAGE - Company Total Asset Base|NIVF (NewGenIvf Group Limited) - Company Total Assets|ATI Physical Therapy Corp (ATIP) - Company Total Asset Base|Aggregate Company Assets CareMax (CMAX)|Company Total Asset Base Kindly MD Inc|LogistiCare - Cumulative Company Assets|Aggregate Asset Value NVOS|SunLink Health Systems, Inc - Company Total Assets|Aggregate Asset Value BACK (imacholdings.comm)